Session

Update renal, bladder and prostate Guidelines 2016, what is changed?

ESU Course 36

  • Location:
    Room 22 (ICM, Level 2)
  • Chair:
     H.G. Van Der Poel, Amsterdam (NL)
  • Aims and objectives of this session

    During the course recent practice changing alterations in the guidelines will be discussed. Based on the clinical recommendations the highlights of the guidelines one prostate, renal and bladder cancer as changed in the 2016 updates will be presented and illustrated by clinical cases. A basic knowledge of the guidelines information is assumed for participating trainees.

Introduction
 H.G. Van Der Poel, Amsterdam (NL)
Update renal cancer: Localized
 A. Volpe, Novara (IT)
Discussion
Update renal cancer: Metastasized
 A. Volpe, Novara (IT)
Discussion
Update bladder cancer: Non-muscle invasive
 B.W.G. Van Rhijn, Amsterdam (NL)
Discussion
Update bladder cancer: Muscle invasive
 B.W.G. Van Rhijn, Badhoevedorp (NL)
Discussion
Update prostate cancer: Localized
 H.G. Van Der Poel, Amsterdam (NL)
Discussion
Update prostate cancer: Metastasized
 H.G. Van Der Poel, Amsterdam (NL)